DexComNASDAQ: DXCM

DXCM and OURA, a company that makes smart rings, are working together to help people make better choices about their diet, exercise, and general health.

On Tuesday, medical device company Dexcom announced that it will put $75 million into Ōura's newest funding round, which gives the smart ring company a valuation of more than $5 billion.

If you want to keep track of your vital signs like an Olympic athlete, you should be excited about the partnership between glucose-monitor company DexCom and Oura smart rings.

SAN DIEGO--(BUSINESS WIRE)--On this World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), a leader in glucose monitoring technology, is urging individuals with diabetes worldwide to start exploring their health. Research indicates that almost 70% of those diagnosed with diabetes felt unsure about how to begin their health journey, and nearly half reported that diabetes has restricted their ability to follow their interests. For National Diab.

The stocks of these mid-sized companies, which have strong competitive advantages, seem appealing because they are undervalued.

This medical device company is struggling, but it is not finished yet.

Investors probably believed that with an exciting new product available, the company should have shown more significant growth.

On Thursday, DexCom, Inc. (DXCM) announced third-quarter results that exceeded expectations.

In the third quarter of 2024, DXCM's earnings and revenues exceeded expectations, driven by the worldwide increase in CGM usage, robust Sensor sales, and entry into new markets.